Genopathy
Gene-Disorder Association · Article
Gene
STK11
Serine/Threonine Kinase 11
Disorder
Lung Cancer
Manually curatedApproved treatment annotated
Association Review

In brief

The association between STK11 (Serine/Threonine Kinase 11) and Lung Cancer is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 13
Compounds 3
Trials 374of 4,672 via STK11 compounds
Publications 22
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
STK11

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Lung Cancer

The disorder

31 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

3 clinical features

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
Interventions

Therapeutics

3 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
07
Human studies

Clinical trials

4,672 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
08
Literature

Reading

22 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
09
Provenance

References & sources

16 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access